Phospholipid transport and remodeling in health and disease

General Physiology and Biophysics

Volumn 30, Issue SPECIAL, 2011, Pages

  Poloncová, Katarína ^a   Griaè, Peter ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Barth syndrome; Cardiolipin; Phosphatidylinositol transfer protein; Phospholipid; Signaling

Indexed keywords

CARDIOLIPIN; PHOSPHOLIPID; CARRIER PROTEIN; LIPID TRANSFER PROTEIN;

BARTH SYNDROME; CELL COMPARTMENTALIZATION; CELLULAR DISTRIBUTION; GENETIC LINKAGE; HEALTH STATUS; HUMAN; LIPID DEGRADATION; LIPOGENESIS; MEDICAL RESEARCH; NONHUMAN; PHOSPHOLIPID TRANSFER; REVIEW; ANIMAL; GENERAL ASPECTS OF DISEASE; HEALTH; METABOLISM; PROTEIN TRANSPORT;

EUKARYOTA;

ANIMALS; BARTH SYNDROME; CARRIER PROTEINS; DISEASE; HEALTH; HUMANS; PHOSPHOLIPIDS; PROTEIN TRANSPORT;

EID: 82255177149     PISSN: 02315882     EISSN: 13384325     Source Type: Journal    
DOI: 10.4149/gpb-2011-SI1-25     Document Type: Review

References (84)

1. Acehan D., Khuchua Z., Houtkooper R. H., Malhotra A., Kaufman J., Vaz F. M., Ren M., Rockman H. A., Stokes D. L., Schlame M. (2009): Distinct effects of tafazzin deletion in differentiated and undifferentiated mitochondria. Mitochondrion 9, 86-95 doi:10.1016/j.mito.2008.12.001
2. Alb J. G., Jr., Phillips S. E., Rostand K., Cui X., Pinxteren J., Cotlin L., Manning T., Guo S., York J. D., Sontheimer H., Collawn J. F., Bankaitis V A. (2002): Genetic ablation of phosphatidylinositol transfer protein function in murine embryonic stem cells. Mol. Biol. Cell. 13, 739-754 doi:10.1091/mbc.01-09- 0457 (Pubitemid 34250343)
3. Alb J. G., Jr., Cortese J. D., Phillips S. E., Albin R. L., Nagy T. R., Hamilton B. A., Bankaitis V. A. (2003): Mice lacking phosphati-dylinositol transfer protein-alpha exhibit spinocerebellar de-generation, intestinal and hepatic steatosis, and hypoglycemia. J. Biol. Chem. 278, 33501-33518 doi:10.1074/jbc.M303591200 (Pubitemid 37055805)
4. Bankaitis V. A., Malehorn D. E., Emr S. D., Greene R. (1989): Te Saccharomyces cerevisiae SEC14 gene encodes a cytosolic fac-tor that is required for transport of secretory proteins from the yeast Golgi complex. J. Cell. Biol. 108, 1271-1281 doi:10.1083/jcb.108.4.1271 (Pubitemid 19097036)
5. Bankaitis V. A., Aitken J. R., Cleves A. E., Dowhan W. (1990): An essential role for a phospholipid transfer protein in yeast Golgi function. Nature 347, 561-562 doi:10.1038/347561a0 (Pubitemid 20341547)
6. Bankaitis V. A., Mousley C. J., Schaaf G. (2010): Te Sec14 super-family and mechanisms for crosstalk between lipid metabolism and lipid signaling. Trends Biochem. Sci. 35, 150-160 doi:10.1016/j.tibs.2009.10.008
7. Barth P. G., Scholte H. R., Berden J. A., Van der Klei-Van Moorsel J. M., Luyt-Houwen I. E., Van ,t Veer-Korthof E. T., Van der Harten J. J., Sobotka-Plojhar M. A. (1983): An X-linked mito-chondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J. Neurol. Sci. 62, 327-355 doi:10.1016/0022-510X(83)90209-5 (Pubitemid 14176259)
8. Barth P. G., Wanders R. J., Vreken P., Janssen E. A., Lam J., Baas F. (1999): X-linked cardioskeletal myopathy and neutropenia (Barth syndrome) (MIM 302060). J. Inherit. Metab. Dis. 22, 555-567 doi:10.1023/A:1005568609936 (Pubitemid 29281043)
9. Barth P. G., Valianpour F., Bowen V M., Lam J., Duran M., Vaz F. M., Wanders R. J. (2004): X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update. Am. J. Med. Genet. A 126A, 349-354 doi:10.1002/ajmg.a. 20660 (Pubitemid 38541803)
10. Beranek A., Rechberger G., Knauer H., Wolinski H., Kohlwein S. D., Leber R. (2009): Identification ofacardiolipin-specific phospholipase encoded by the gene CLD1 (YGR110W) in yeast. J. Biol. Chem. 284, 11572-11578 doi:10.1074/jbc.M805511200
11. Bione S., DAdamo P., Maestrini E., Gedeon A. K., Bolhuis P. A., Toniolo D. (1996): A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nat. Genet. 12, 385-389 doi:10.1038/ng0496-385 (Pubitemid 26106250)
12. Bomar J. M., Benke P. J., Slattery E. L., Puttagunta R., Taylor L. P., Seong E., Nystuen A., Chen W., Albin R. L., Patel P. D., Kit-tles R. A., Sheffield V C., Burmeister M. (2003): Mutations in a novel gene encoding a CRAL-TRIO domain cause human Cayman ataxia and ataxia/dystonia in the jittery mouse. Nat. Genet. 35, 264-269 doi:10.1038/ng1255 (Pubitemid 37363181)
13. Cantlay A. M., Shokrollahi K., Allen J. T., Lunt P. W., Newbury-Ecob R. A., Steward C. G. (1999): Genetic analysis of the G4.5 gene in families with suspected Barth syndrome. J. Pediatr. 135, 311-315 doi:10.1016/S0022-3476(99) 70126-5 (Pubitemid 30180503)
14. Chance B., Sies H., Boveris A. (1979): Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59, 527-605 (Pubitemid 9236599)
15. Chen J., Delannoy M., Odwin S., He P., Trush M. A., Yager J. D. (2003): Enhanced mitochondrial gene transcript, ATP, bcl-2 protein levels, and altered glutathione distribution in ethinyl estradiol-treated cultured female rat hepatocytes. Toxicol. Sci. 75, 271-278 doi:10.1093/toxsci/kfg183 (Pubitemid 37220274)
16. Chen S., He Q., Greenberg M. L. (2008): Loss of tafazzin in yeast leads to increased oxidative stress during respiratory growth. Mol. Microbiol. 68, 1061-1072 doi:10.1111/j.1365-2958.2008.06216.x (Pubitemid 351581071)
17. Chernomordik L. V., Kozlov M. M. (2005): Membrane hemifusion: crossing a chasm in two leaps. Cell 123, 375-382 doi:10.1016/j.cell.2005.10.015 (Pubitemid 41546669)
18. Chernomordik L. V., Zimmerberg J., Kozlov M. M. (2006): Mem-branes of the world unite! J. Cell. Biol. 175, 201-207 doi:10.1083/jcb.200607083 (Pubitemid 44631414)
19. Chicco A. J., Sparagna G. C. (2007): Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am. J. Physiol. Cell Physiol. 292, C33-44 doi:10.1152/ajpcell.00243.2006 (Pubitemid 46115119)
20. Christodoulou J., McInnes R. R., Jay V., Wilson G., Becker L. E., Lehotay D. C., Platt B. A., Bridge P. J., Robinson B. H., Clarke J. T. (1994): Barth syndrome: clinical observations and genetic linkage studies. Am. J. Med. Genet. 50, 255-264 doi:10.1002/ajmg.1320500309 (Pubitemid 24109135)
21. Cichowski K., Jacks T. (2001): NF1 tumor suppressor gene function: narrowing the GAP. Cell 104, 593-604 doi:10.1016/S0092-8674(01)00245-8 (Pubitemid 32201953)
22. Claypool S. M., Boontheung P., McCaffery J. M., Loo J. A., Koehler C. M. (2008): Te cardiolipin transacylase, tafazzin, associates with two distinct respiratory components providing insight into Barth syndrome. Mol. Biol. Cell. 19, 5143-5155 doi:10.1091/mbc.E08-09-0896
23. Cleves A. E., Novick P. J., Bankaitis V. A. (1989): Mutations in the SAC1 gene suppress defects in yeast Golgi and yeast actin func-tion. J. Cell. Biol. 109, 2939-2950 doi:10.1083/jcb.109.6.2939 (Pubitemid 20011920)
24. Cleves A. E., McGee T. P., Whitters E. A., Champion K. M., Aitken J. R., Dowhan W., Goebl M., Bankaitis V. A. (1991): Mutations in the CDP-choline pathway for phospholipid biosynthesis bypass the requirement for an essential phospholipid transfer protein. Cell 64, 789-800 doi:10.1016/0092-8674(91)90508-V (Pubitemid 121001166)
25. Cockcrof S. (1998): Phosphatidylinositol transfer proteins: a requirement in signal transduction and vesicle traffic. Bioessays. 20, 423-432 doi:10.1002/(SICI)1521-1878(199805)20:5<423::AID-BIES9>3.0.CO;2-O
26. Cockcrof S. (2001): Phosphatidylinositol transfer proteins couple lipid transport to phosphoinositide synthesis. Semin. Cell Dev. Biol. 12, 183-191 doi:10.1006/scdb.2000.0235
27. Cockcrof S., Carvou N. (2007): Biochemical and biological func-tions of class I phosphatidylinositol transfer proteins. Biochim. Biophys. Acta. 1771, 677-691 (Pubitemid 46856893)
28. Costa V., Amorim M. A., Reis E., Quintanilha A., Moradas-Fer-reira P. (1997): Mitochondrial superoxide dismutase is essen-tial for ethanol tolerance of Saccharomyces cerevisiae in the post-diauxic phase. Microbiology 143 (Pt 5), 1649-1656 doi:10.1099/00221287-143-5-1649 (Pubitemid 27230754)
29. Costa V., Moradas-Ferreira P. (2001): Oxidative stress and signal transduction in Saccharomyces cerevisiae: insights into ageing, apoptosis and diseases. Mol. Aspects Med. 22, 217-246 doi:10.1016/S0098-2997(01)00012-7 (Pubitemid 33000523)
30. Cunningham E., Tan S. K., Swigart P., Hsuan J., Bankaitis V., Cockcrof S. (1996): Te yeast and mammalian isoforms of phosphatidylinositol transfer protein can all restore phospholi- pase C-mediated inositol lipid signaling in cytosol-depleted RBL-2H3 and HL-60 cells. Proc. Natl. Acad. Sci. USA 93, 6589-6593 doi:10.1073/pnas.93.13.6589 (Pubitemid 26230352)
31. DAngelo I., Welti S., Bonneau F., Scheffzek K. (2006): A novel bi-partite phospholipid-binding module in the neurofibromatosis type 1 protein. EMBO Rep. 7, 174-179 doi:10.1038/sj.embor.7400602
32. De Vries K. J., Westerman J., Bastiaens P. I., Jovin T. M., Wirtz K. W., Snoek G. T. (1996): Fluorescently labeled phosphatidylinositol transfer protein isoforms (alpha and beta), microinjected into fetal bovine heart endothelial cells, are targeted to distinct intracellular sites. Exp. Cell Res. 227, 33-39 doi:10.1006/excr.1996.0246 (Pubitemid 26293412)
33. Di Paolo G., De Camilli P. (2006): Phosphoinositides in cell regula-tion and membrane dynamics. Nature 443, 651-657 doi:10.1038/nature05185 (Pubitemid 44564702)
34. Du X., Takagi H. (2007): N-Acetyltransferase Mpr1 confers ethanol tolerance on Saccharomyces cerevisiae by reducing reactive oxygen species. Appl. Microbiol. Biotechnol. 75, 1343-1351 doi:10.1007/s00253-007-0940-x (Pubitemid 46976659)
35. Fang M., Kearns B. G., Gedvilaite A., Kagiwada S., Kearns M., Fung M. K., Bankaitis V. A. (1996): Kes1p shares homology with human oxysterol binding protein and participates in a novel regulatory pathway for yeast Golgi-derived transport vesicle biogenesis. EMBO J. 15, 6447-6459 (Pubitemid 26413778)
36. Griac P., Holic R., Tahotna D. (2006): Phosphatidylinositol-transfer protein and its homologues in yeast. Biochem. Soc. Trans. 34, 377-380 doi:10.1042/BST0340377 (Pubitemid 43953991)
37. Gu Z., Valianpour F., Chen S., Vaz F. M., Hakkaart G. A., Wanders R. J., Greenberg M. L. (2004): Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome. Mol. Microbiol. 51, 149-158 doi:10.1046/j.1365-2958.2003.03802.x (Pubitemid 38031078)
38. Hama H., Schnieders E. A., Torner J., Takemoto J. Y., DeWald D. B. (1999): Direct involvement of phosphatidylinositol 4-phosphate in secretion in the yeast Saccharomyces cerevisiae. J. Biol. Chem. 274, 34294-34300 doi:10.1074/jbc.274.48.34294 (Pubitemid 129511771)
39. Hamilton B. A., Smith D. J., Mueller K. L., Kerrebrock A. W., Bronson R. T., van Berkel V., Daly M. J., Kruglyak L., Reeve M. P., Nemhauser J. L., Hawkins T. L., Rubin E. M., Lander E. S. (1997): Te vibrator mutation causes neurodegeneration via reduced expression of PITP alpha: positional complementation cloning and extragenic suppression. Neuron 18, 711-722 doi:10.1016/S0896-6273(00)80312-8 (Pubitemid 27232783)
40. Hastings R., Steward C., Tsai-Goodman B., Newbury-Ecob R. (2009): Dysmorphology of Barth syndrome. Clin. Dysmorphol. 18, 185-187 doi:10.1097/MCD.0b013e32832a9e62
41. HauffK. D., Hatch G. M. (2006): Cardiolipin metabolism and Barth Syndrome. Prog. Lipid Res. 45, 91-101 doi:10.1016/j.plipres.2005.12.001 (Pubitemid 43248730)
42. Holthuis J. C., Levine T. P. (2005): Lipid traffic: floppy drives and a superhighway Nat Rev. Mol. Cell Biol. 6, 209-220 doi:10.1038/nrm1591 (Pubitemid 40314922)
43. Imai H., Koumura T., Nakajima R., Nomura K., Nakagawa Y. (2003): Protection from inactivation of the adenine nucleotide translocator during hypoglycaemia-induced apoptosis by mito-chondrial phospholipid hydroperoxide glutathione peroxidase. Biochem. J. 371, 799-809 doi:10.1042/BJ20021342 (Pubitemid 36578879)
44. Jiang F., Ryan M. T., Schlame M., Zhao M., Gu Z., Klingenberg M., Pfanner N., Greenberg M. L. (2000): Absence of cardiolipin in the crd1 null mutant results in decreased mitochondrial membrane potential and reduced mitochondrial function. J. Biol. Chem. 275, 22387-22394 doi:10.1074/jbc.M909868199 (Pubitemid 30621825)
45. Johnston J., Kelley R. I., Feigenbaum A., Cox G. F., Iyer G. S., Fu-nanage V. L., Proujansky R. (1997): Mutation characterization and genotype-phenotype correlation in Barth syndrome. Am. J. Hum. Genet. 61, 1053-1058 doi:10.1086/301604 (Pubitemid 27492312)
46. Kelley R. I., Cheatham J. P., Clark B. J., Nigro M. A., Powell B. R., Sherwood G. W., Sladky J. T., Swisher W. P. (1991): X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria. J. Pediatr. 119, 738-747 doi:10.1016/S0022-3476(05)80289-6
47. Koshkin V., Greenberg M. L. (2000): Oxidative phosphorylation in cardiolipin-lacking yeast mitochondria. Biochem. J. 347 Pt 3, 687-691 doi:10.1042/0264-6021:3470687 (Pubitemid 30260957)
48. LeBlanc M. A., McMaster C. R. (2010): Surprising roles for phos-pholipid binding proteins revealed by high throughput genetics. Biochem. Cell Biol. 88, 565-574 doi:10.1139/O09-171
49. Lev S. (2010) Non-vesicular lipid transport by lipid-transfer proteins and beyond. Nature Rev. Mol. Cell Biol. 11, 739-750 doi:10.1038/nrm2971
50. Levine T., Loewen C. (2006): Inter-organelle membrane con-tact sites: through a glass, darkly. Curr. Opin. Cell Biol. 18, 371-378 doi:10.1016/j.ceb. 2006.06.011 (Pubitemid 44016060)
51. Li G., Chen S., Tompson M. N., Greenberg M. L. (2007): New insights into the regulation of cardiolipin biosynthesis in yeast: implications for Barth syndrome. Biochim. Biophys. Acta. 1771, 432-441 (Pubitemid 46428608)
52. Ma L., Vaz F. M., Gu Z., Wanders R. J., Greenberg M. L. (2004): Te human TAZ gene complements mitochondrial dysfunction in the yeast taz1 delta mutant. Implications for Barth syndrome. J. Biol. Chem. 279, 44394-44399 doi:10.1074/jbc.M405479200 (Pubitemid 39430844)
53. Macchioni L., Corazzi T., Davidescu M., Francescangeli E., Roberti R., Corazzi L. (2010): Cytochrome c redox state influences the binding and release of cytochrome c in model membranes and in brain mitochondria. Mol. Cell. Biochem. 341, 149-157 doi:10.1007/s11010-010-0446-1
54. Maw M. A., Kennedy B., Knight A., Bridges R., Roth K. E., Mani E. J., Mukkadan J. K., Nancarrow D., Crabb J. W., Denton M. J. (1997): Mutation of the gene encoding cellular retinaldehyde-binding protein in autosomal recessive retinitis pigmentosa. Nat. Genet. 17, 198-200 doi:10.1038/ng1097-198
55. McLean L. R., Phillips M. C. (1984): Kinetics of phosphatidylcholine and lysophosphatidylchoine exchange between unilamellar vesicles. Biochemistry 23, 4624-4630 doi:10.1021/bi00315a017
56. Meier R., Tomizaki T., Schulze-Briese C., Baumann U., Stocker A. (2003): Te molecular basis of vitamin E retention: structure of human alpha-tocopherol transfer protein. J. Mol. Biol. 331, 725-734 doi:10.1016/S0022-2836(03)00724-1 (Pubitemid 36937156)
57. Milligan S. C., Alb J. G., Jr., Elagina R. B., Bankaitis V. A., Hyde D. R. (1997): Te phosphatidylinositol transfer protein domain of Drosophila retinal degeneration B protein is essential for photoreceptor cell survival and recovery from light stimulation. J. Cell. Biol. 139, 351-363 doi:10.1083/jcb.139.2.351 (Pubitemid 27459309)
58. Min K. C., Kovall R. A., Hendrickson W. A. (2003): Crystal structure of human alpha-tocopherol transfer protein bound to its ligand: implications for ataxia with vitamin E deficiency Proc. Natl. Acad. Sci. U.S.A. 100, 14713-14718 doi:10.1073/pnas.2136684100 (Pubitemid 37517956)
59. Murray J. P., McMaster C. R. (2005): Nte1p-mediated deacylation of phosphatidylcholine functionally interacts with Sec14p. J. Biol. Chem. 280, 8544-8552 doi:10.1074/jbc.M413999200 (Pubitemid 40349759)
60. Ouahchi K., Arita M., Kayden H., Hentati F., Ben Hamida M., Sokol R., Arai H., Inoue K., Mandel J. L., Koenig M. (1995): Ataxia with isolated vitamin E deficiency is caused by muta- tions in the alpha-tocopherol transfer protein. Nat. Genet. 9, 141-145 doi:10.1038/ng0295-141
61. Pfeiffer K., GohilV, Stuart R. A., Hunte C., Brandt U., Greenberg M. L., Schagger H. (2003): Cardiolipin stabilizes respiratory chain supercomplexes. J. Biol. Chem. 278, 52873-52880 doi:10.1074/jbc.M308366200 (Pubitemid 38035887)
62. Sha B., Phillips S. E., Bankaitis V. A., Luo M. (1998): Crystal structure of the Saccharomyces cerevisiae phosphatidylinositol-transfer protein. Nature 391, 506-510 doi:10.1038/35179 (Pubitemid 28086554)
63. Schaaf G., Ortlund E. A., Tyeryar K. R., Mousley C. J., Ile K. E., Garrett T. A., Ren J., Woolls M. J., Raetz C. R., Redinbo M. R., Bankaitis V. A. (2008): Functional anatomy of phospholipid binding and regulation of phosphoinositide homeostasis by proteins of the sec14 superfamily. Mol. Cell 29, 191-206 doi:10.1016/j.molcel.2007.11.026 (Pubitemid 351172821)
64. Schlame M., Rua D., Greenberg M. L. (2000): Te biosynthesis and functional role of cardiolipin. Prog. Lipid Res. 39, 257-288 doi:10.1016/S0163-7827(00)00005-9 (Pubitemid 30224706)
65. Schlame M., Towbin J. A., Heerdt P. M., Jehle R., DiMauro S., Blanck T. J. (2002): Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome. Ann. Neurol. 51, 634-637 doi:10.1002/ana.10176 (Pubitemid 34438705)
66. Schmidt M. R., Birkebaek N., Gonzalez I., Sunde L. (2004): Barth syndrome without 3-methylglutaconic aciduria. Acta Paediatr. 93, 419-421 doi:10.1111/j.1651-2227.2004.tb02974.x (Pubitemid 38316572)
67. Spencer C. T., Byrne B. J., Gewitz M. H., Wechsler S. B., Kao A. C., Gerstenfeld E. P., Merliss A. D., Carboni M. P., Bryant R. M. (2005): Ventricular arrhythmia in the X-linked cardiomyopathy Barth syndrome. Pediatr. Cardiol. 26, 632-637 doi:10.1007/s00246-005-0873-z (Pubitemid 43015800)
68. Sreenivas A., Patton-Vogt J. L., Bruno V., Griac P., Henry S. A. (1998): A role for phospholipase D (Pld1p) in growth, secretion, and regulation of membrane lipid synthesis in yeast. J. Biol. Chem. 273, 16635-16638 doi:10.1074/jbc.273.27.16635 (Pubitemid 28311681)
69. Steward C. G., Newbury-Ecob R. A., Hastings R., Smithson S. F., Tsai-Goodman B., Quarrell O. W., Kulik W., Wanders R., Pennock M., Williams M., Cresswell J. L., Gonzalez I. L., Brennan P. (2010): Barth syndrome: an X-linked cause of fetal cardio-myopathy and stillbirth. Prenat. Diagn. 30, 970-976 doi:10.1002/pd.2599
70. Tanaka S., Hosaka K. (1994): Cloning of a cDNA encoding a second phosphatidylinositol transfer protein of rat brain by complementation of the yeast sec14 mutation. J. Biochem. 115, 981-984 (Pubitemid 24159926)
71. Turrens J. F. (2003): Mitochondrial formation of reactive oxygen species. J. Physiol. 552, 335-344 doi:10.1113/jphysiol.2003.049478 (Pubitemid 37321833)
72. Vaz F. M., Houtkooper R. H., Valianpour F., Barth P. G., Wanders R. J. (2003): Only one splice variant of the human TAZ gene encodes a functional protein with a role in cardiolipin metabo-lism. J. Biol. Chem. 278, 43089-43094 doi:10.1074/jbc.M305956200 (Pubitemid 37345925)
73. Vreken P., Valianpour F., Nijtmans L. G., Grivell L. A., Plecko B., Wanders R. J., Barth P. G. (2000): Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem. Biophys. Res. Commun. 279, 378-382 doi:10.1006/bbrc.2000.3952 (Pubitemid 32016725)
74. Wang X. (2001): Teexpandingrole of mitochondria in apoptosis. Genes Dev. 15, 2922-2933
75. Welti S., Fraterman S., D'Angelo I., Wilm M., Scheffzek K. (2007): Te sec14 homology module of neurofibromin binds cellular glycerophospholipids: mass spectrometry and structure of a lipid complex. J. Mol. Biol. 366, 551-562 doi:10.1016/j.jmb.2006.11.055 (Pubitemid 46136212)
76. Wirtz K. W. (1991): Phospholipid transfer proteins. Annu. Rev. Biochem. 60, 73-99 doi:10.1146/annurev.bi.60.070191.000445
77. Wolf C., Quinn P. J. (2008): Lipidomics: practical aspects and ap-plications. Prog. Lipid Res. 47, 15-36
78. Wu W. I., Routt S., Bankaitis V. A., Voelker D. R. (2000): A new gene involved in the transport-dependent metabolism of phosphati- dylserine, PSTB2/PDR17, shares sequence similarity with the gene encoding the phosphatidylinositol/phosphatidylcholine transfer protein, SEC14. J. Biol. Chem. 275, 14446-14456 doi:10.1074/jbc.275.19.14446 (Pubitemid 30339731)
79. Wu W I., Voelker D. R. (2001): Characterization of phosphatidylser- ine transport to the locus of phosphatidylserine decarboxylase 2 in permeabilized yeast. J. Biol. Chem. 276, 7114-7121 doi:10.1074/jbc.M010278200
80. Xie Z., Fang M., Rivas M. P., Faulkner A. J., Sternweis P. C., Enge-brecht J. A., Bankaitis V. A. (1998): Phospholipase D activity is required for suppression of yeast phosphatidylinositol transfer protein defects. Proc. Natl. Acad. Sci. U.S.A. 95, 12346-12351 doi:10.1073/pnas.95.21.12346 (Pubitemid 28483768)
81. Xie Z., Fang M., Bankaitis V. A. (2001): Evidence for an intrinsic toxicity of phosphatidylcholine to Sec14p-dependent protein transport from the yeast Golgi complex. Mol. Biol. Cell 12, 1117-1129 (Pubitemid 33052003)
82. Xu Y., Condell M., Plesken H., Edelman-Novemsky I., Ma J., Ren M., Schlame M. (2006a): A Drosophila model of Barth syndrome. Proc. Natl. Acad. Sci. U.S.A. 103, 11584-11588 doi:10.1073/pnas.0603242103 (Pubitemid 44182495)
83. Xu Y., Malhotra A., Ren M., Schlame M. (2006b): Te enzymatic function of tafazzin. J. Biol. Chem. 281, 39217-39224 doi:10.1074/jbc.M606100200 (Pubitemid 46041881)
84. Zhang M., Mileykovskaya E., Dowhan W. (2002): Gluing the respi-ratory chain together. Cardiolipin is required for supercomplex formation in the inner mitochondrial membrane. J. Biol. Chem. 277, 43553-43556 doi:10.1074/jbc. C200551200 (Pubitemid 36157767)